Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Epidemiology|August 28, 1999
Bayesian monitoring of phase II trials in cancer chemopreventionK A Cronin, L S Freedman, R Lieberman, et al.
The Laryngoscope|September 25, 2001
Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glandsM D Gibbons, U Manne, W R Carroll, et al.
Cancer|January 5, 1999
Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumorU Manne, H L Weiss, R B Myers, et al.
The American Journal of Clinical Nutrition|November 4, 2000
Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theoryR L Weinsier, T R Nagy, G R Hunter, et al.
BMC Infectious Diseases|August 24, 2001
Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillanceL J Yee, H L Weiss, R G Langner, et al.
Neurosurgery|June 1, 1997
Brain edema in meningiomas is associated with increased vascular endothelial growth factor expressionC K Goldman, S Bharara, C A Palmer, et al.
Statistics in Medicine|August 21, 2001
Phase specific analysis of herpes zoster associated pain data: a new statistical approachR B Arani, S J Soong, H L Weiss, et al.
The Journal of Urology|September 24, 1999
Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasiaR B Poczatek, R B Myers, U Manne, et al.
Urology|April 11, 2001
Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancerH L Weiss, D A Urban, W E Grizzle, et al.
The Journal of Urology|February 18, 1999
Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinomaR B Myers, D K Oelschlager, P N Coan, et al.
Pageof 4